Wang Qi, Amato Stephen P, Rubitski David M, Hayward Matthew M, Kormos Bethany L, Verhoest Patrick R, Xu Lan, Brandon Nicholas J, Ehlers Michael D
Neuroscience & Pain Research Unit, BioTherapeutics Research and Development, Pfizer Inc. Cambridge, Massachusetts (Q.W., S.P.A., D.M.R., N.J.B., M.D.E.); Center of Chemistry Innovation and Excellence, Pfizer Inc., Groton, Connecticut (M.M.H.); Neuroscience Medicinal Chemistry, Pfizer Inc., Cambridge, Massachusetts (B.L.K., P.R.V.);and Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts (L.X.)
Neuroscience & Pain Research Unit, BioTherapeutics Research and Development, Pfizer Inc. Cambridge, Massachusetts (Q.W., S.P.A., D.M.R., N.J.B., M.D.E.); Center of Chemistry Innovation and Excellence, Pfizer Inc., Groton, Connecticut (M.M.H.); Neuroscience Medicinal Chemistry, Pfizer Inc., Cambridge, Massachusetts (B.L.K., P.R.V.);and Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts (L.X.).
J Pharmacol Exp Ther. 2016 Feb;356(2):410-23. doi: 10.1124/jpet.115.229880. Epub 2015 Dec 8.
Traf2- and Nck-interacting kinase (TNIK) is a serine/threonine kinase highly expressed in the brain and enriched in the postsynaptic density of glutamatergic synapses in the mammalian brain. Accumulating genetic evidence and functional data have implicated TNIK as a risk factor for psychiatric disorders. However, the endogenous substrates of TNIK in neurons are unknown. Here, we describe a novel selective small molecule inhibitor of the TNIK kinase family. Using this inhibitor, we report the identification of endogenous neuronal TNIK substrates by immunoprecipitation with a phosphomotif antibody followed by mass spectrometry. Phosphorylation consensus sequences were defined by phosphopeptide sequence analysis. Among the identified substrates were members of the delta-catenin family including p120-catenin, δ-catenin, and armadillo repeat gene deleted in velo-cardio-facial syndrome (ARVCF), each of which is linked to psychiatric or neurologic disorders. Using p120-catenin as a representative substrate, we show TNIK-induced p120-catenin phosphorylation in cells requires intact kinase activity and phosphorylation of TNIK at T181 and T187 in the activation loop. Addition of the small molecule TNIK inhibitor or knocking down TNIK by two shRNAs reduced endogenous p120-catenin phosphorylation in cells. Together, using a TNIK inhibitor and phosphomotif antibody, we identify endogenous substrates of TNIK in neurons, define consensus sequences for TNIK, and suggest signaling pathways by which TNIK influences synaptic development and function linked to psychiatric and neurologic disorders.
肿瘤坏死因子受体相关因子2与Nck相互作用激酶(TNIK)是一种丝氨酸/苏氨酸激酶,在大脑中高度表达,并富集于哺乳动物大脑谷氨酸能突触的突触后致密区。越来越多的遗传学证据和功能数据表明TNIK是精神疾病的一个风险因素。然而,TNIK在神经元中的内源性底物尚不清楚。在这里,我们描述了一种新型的TNIK激酶家族选择性小分子抑制剂。利用这种抑制剂,我们通过用磷酸化基序抗体进行免疫沉淀,随后进行质谱分析,报告了内源性神经元TNIK底物的鉴定。通过磷酸肽序列分析确定了磷酸化共有序列。在鉴定出的底物中,有δ-连环蛋白家族的成员,包括p120-连环蛋白、δ-连环蛋白和腭心面综合征(ARVCF)中缺失的犰狳重复基因,它们各自都与精神或神经疾病有关。以p120-连环蛋白作为代表性底物,我们表明TNIK在细胞中诱导的p120-连环蛋白磷酸化需要完整的激酶活性以及激活环中TNIK的T181和T187位点的磷酸化。添加小分子TNIK抑制剂或通过两种短发夹RNA敲低TNIK可降低细胞内源性p120-连环蛋白的磷酸化。总之,利用TNIK抑制剂和磷酸化基序抗体,我们鉴定了神经元中TNIK的内源性底物,确定了TNIK的共有序列,并提出了TNIK影响与精神和神经疾病相关的突触发育和功能的信号通路。